| 摘要 |
An administration method is provided, in which a composition comprising a forskolin 1alpha,9alpha-carbonate compound is administered to a human subject. According to an embodiment, the forskolin 1alpha,9alpha-carbonate compound has a skeletal structure of 8,13-epoxy-1alpha,6beta,7beta,9alpha-tetrahydroxylabd-14-en-11-one. A carbonyl group links the 1-position hydroxy oxygen and the 9-position hydroxy oxygen to one another for forming a carbonate ester ring. Hydrogen is appended to the 6-position hydroxy oxygen. A hydrogen or an acetyl group is appended to the 7-position hydroxy oxygen.
|
